肠易激综合征患者的肠道微生物群——一项系统综述
该研究通过检索MEDLINE、EMBASE、Cochrane CDSR和CENTRAL(截至2018年4月2日),纳入22篇文章中的24项病例对照研究,比较成人或儿童肠易激综合征(IBS)患者与健康对照的粪便或结肠微生物组。结果显示,与对照相比,IBS患者中肠杆菌科(变形菌门)、乳杆菌科和拟杆菌属增多,而未培养的梭菌目I、粪杆菌属(包括普拉梭菌)和双歧杆菌属减少;微生物多样性在IBS患者中降低或无差异。超过40%的研究未说明病例与对照是否可比(未描述性别和/或年龄特征)。
要点
- 与健康对照相比,IBS患者肠道中肠杆菌科、乳杆菌科和拟杆菌属增多。
- 与健康对照相比,IBS患者肠道中未培养的梭菌目I、粪杆菌属和双歧杆菌属减少。
- 微生物多样性在IBS患者中降低或无差异,超过40%的研究未说明病例与对照是否可比。
核心结论
- 系统综述发现与IBS患者微生物组相关的特定细菌,但需要研究确定这些微生物是IBS的产物还是原因。
研究设计与样本
- 系统综述,检索MEDLINE、EMBASE、Cochrane CDSR和CENTRAL(截至2018年4月2日),纳入22篇文章中的24项病例对照研究,比较成人或儿童IBS患者与健康对照的粪便或结肠微生物组。
主要发现
- 与对照相比,IBS患者中肠杆菌科(变形菌门)、乳杆菌科和拟杆菌属增多。
- 与对照相比,IBS患者中未培养的梭菌目I、粪杆菌属(包括普拉梭菌)和双歧杆菌属减少。
- 微生物多样性在IBS患者中降低或无差异。
- 超过40%的纳入研究未说明病例与对照是否可比(未描述性别和/或年龄特征)。
局限性
- 超过40%的纳入研究未说明病例与对照是否可比(未描述性别和/或年龄特征)。
- 需要研究确定这些微生物是IBS的产物还是原因。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Irritable bowel syndrome (IBS) is common but difficult to treat. Altering the gut microbiota has been proposed as a strategy for treatment of IBS, but the association between the gut microbiome and IBS symptoms has not been well established. We performed a systematic review to explore evidence for this association. METHODS: We searched databases, including MEDLINE, EMBASE, Cochrane CDSR, and CENTRAL, through April 2, 2018 for case-control studies comparing the fecal or colon microbiomes of adult or pediatric patients with IBS with microbiomes of healthy individuals (controls). The primary outcome was differences in specific gut microbes between patients with IBS and controls. RESULTS: The search identified 2631 citations; 24 studies from 22 articles were included. Most studies evaluated adults presenting with various IBS subtypes. Family Enterobacteriaceae (phylum Proteobacteria), family Lactobacillaceae, and genus Bacteroides were increased in patients with IBS compared with controls, whereas uncultured Clostridiales I, genus Faecalibacterium (including Faecalibacterium prausnitzii), and genus Bifidobacterium were decreased in patients with IBS. The diversity of the microbiota was either decreased or not different in IBS patients compared with controls. More than 40% of included studies did not state whether cases and controls were comparable (did not describe sex and/or age characteristics). CONCLUSIONS: In a systematic review, we identified specific bacteria associated with microbiomes of patients with IBS vs controls. Studies are needed to determine whether these microbes are a product or cause of IBS.
引用
- Pittayanon R, Lau JT, Yuan Y, et al. Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review. Gastroenterology. 2019. PMID: 30940523. doi:10.1053/j.gastro.2019.03.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。